Literature DB >> 17631429

Identification of diadenosine triphosphate in Brugia malayi by reverse phase high performance liquid chromatography and MALDI mass spectrometry.

Michael Kron1, Joseph Leykam, Jessica Kopaczewski, Isaac Matus.   

Abstract

The presence of diadenosine oligophosphates (ApnA) in eukaryotic pathogens has been difficult technically to assess and thus is often overlooked. ApnA are a family of intercellular and intracellular signaling molecules and their biological activities differ relative to the number of phosphate moieties. The application of mass spectrometry to differentiate nucleotide phosphates has been limited by the high salt content in tissue extracts, enzymatic reactions or high performance liquid chromatography (HPLC) buffers, as well as the potential for sample loss when processing and desalting small biological samples. To address this problem a simple reverse phase HPLC (RP-HPLC) method using volatile organic buffers at low pH was developed to create elution profiles of adenosine and diadenosine phosphates. To test this method on a eukaryotic pathogen, small intravascular human filarial parasites (Brugia malayi) were extracted in phosphate buffered saline and a nucleotide phosphate profile was visualized by RP-HPLC. A major peak eluting at 10.4 min was analyzed directly by mass spectrometry and this confirmed the presence of significant quantities of diadenosine triphosphate, Ap3A. Application of this simplified RP-HPLC method will facilitate research on the normal and pathophysiological effects of ApnA particularly in situations when analysis of small biological samples is required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631429      PMCID: PMC2044565          DOI: 10.1016/j.jchromb.2007.06.014

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  23 in total

Review 1.  Purinergic and pyrimidinergic receptors as potential drug targets.

Authors:  M Williams; M F Jarvis
Journal:  Biochem Pharmacol       Date:  2000-05-15       Impact factor: 5.858

Review 2.  P2 purinergic receptors: modulation of cell function and therapeutic potential.

Authors:  G Burnstock; M Williams
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

3.  Presence of diadenosine polyphosphates in human tears.

Authors:  Jesús Pintor; Gonzalo Carracedo; M Carmen Alonso; Alfredo Bautista; Assumpta Peral
Journal:  Pflugers Arch       Date:  2001-08-23       Impact factor: 3.657

4.  Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells.

Authors:  K Patel; A Barnes; J Camacho; C Paterson; R Boughtflower; D Cousens; F Marshall
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

5.  AppppA and related adenylylated nucleotides are synthesized as a consequence of oxidation stress.

Authors:  B R Bochner; P C Lee; S W Wilson; C W Cutler; B N Ames
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

6.  Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers.

Authors:  H C Pace; S C Hodawadekar; A Draganescu; J Huang; P Bieganowski; Y Pekarsky; C M Croce; C Brenner
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

7.  A novel assay for determination of diadenosine polyphosphates in human platelets: studies in normotensive subjects and in patients with essential hypertension.

Authors:  P Hollah; M Hausberg; M Kosch; M Barenbrock; M Letzel; E Schlatter; K H Rahn
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

8.  In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.

Authors:  Renata Kowara; Aldona A Karaczyn; Matthew J Fivash; Kazimierz S Kasprzak
Journal:  Chem Res Toxicol       Date:  2002-03       Impact factor: 3.739

9.  Identification and quantification of diadenosine polyphosphate concentrations in human plasma.

Authors:  Joachim Jankowski; Vera Jankowski; Udo Laufer; Markus van der Giet; Lars Henning; Martin Tepel; Walter Zidek; Hartmut Schlüter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-08       Impact factor: 8.311

10.  Expression, localization and alternative function of cytoplasmic asparaginyl-tRNA synthetase in Brugia malayi.

Authors:  Michael Kron; Michael Petridis; Youli Milev; Joseph Leykam; Michael Härtlein
Journal:  Mol Biochem Parasitol       Date:  2003-06       Impact factor: 1.759

View more
  1 in total

1.  Brugia malayi Asparaginyl-tRNA Synthetase Stimulates Endothelial Cell Proliferation, Vasodilation and Angiogenesis.

Authors:  Jeeva Jothi D; Muthu Dhanraj; Shanmugam Solaiappan; Sanjana Sivanesan; Michael Kron; Anuradha Dhanasekaran
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.